Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus T Jensen

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
European Heart Journal. Cardiovascular Imaging|November 15, 2018
Predictive value of echocardiography in Type 2 diabetesPeter G Jørgensen, Tor Biering-Sørensen, Rasmus Mogelvang, et al.
European Heart Journal. Cardiovascular Imaging|September 5, 2020
Sex differences in the association between myocardial function and prognosis in type 1 diabetes without known heart disease: the Thousand & 1 StudyMats Christian Højbjerg Lassen, Tor Biering-Sørensen, Peter Godsk Jørgensen, et al.
Respiratory Medicine|July 10, 2026
Beta-blockers and mortality after myocardial infarction in patients with and without chronic obstructive pulmonary disease - A Danish nationwide cohort study of 96,567 patientsDaniel B Rasmussen, Howraman Meteran, Morten Lamberts, et al.
JACC. Cardiovascular Imaging|February 17, 2020
Post-Systolic Shortening by Speckle Tracking Echocardiography Predicts Cardiac Events in Type 2 DiabetesPhilip Brainin, Magnus T Jensen, Tor Biering-Sørensen, et al.
European Heart Journal. Cardiovascular Imaging|August 28, 2023
Prognostic value of myocardial performance index in individuals with type 1 and type 2 diabetes: Thousand&1 and Thousand&2 studiesHashmat Sayed Zohori Bahrami, Peter Godsk Jørgensen, Jens Dahlgaard Hove, et al.
Cardiovascular Diabetology|September 1, 2019
Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetesRegitse H Christensen, Bernt Johan von Scholten, Christian S Hansen, et al.
International Journal of Cardiology|May 13, 2019
An echocardiographic substrate for dyspnea identifies high risk patients with type 2 diabetesPeter G Jørgensen, Morten Schou, Tor Biering-Sørensen, et al.
Diabetes, Obesity & Metabolism|February 12, 2017
Effect of exercise combined with glucagon-like peptide-1 receptor agonist treatment on cardiac function: A randomized double-blind placebo-controlled clinical trialPeter G Jørgensen, Magnus T Jensen, Pernille Mensberg, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|November 2, 2020
Prognostic Value of Early Systolic Lengthening by Strain Imaging in Type 2 DiabetesPhilip Brainin, Tor Biering-Sørensen, Magnus T Jensen, et al.
Journal of Diabetes and Its Complications|April 29, 2020
Effect of dapagliflozin on cardiac function in people with type 2 diabetes and albuminuria - A double blind randomized placebo-controlled crossover trialMie K Eickhoff, Flemming J Olsen, Marie Frimodt-Møller, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
European Heart Journal. Cardiovascular Imaging|November 15, 2018
Predictive value of echocardiography in Type 2 diabetesPeter G Jørgensen, Tor Biering-Sørensen, Rasmus Mogelvang, et al.
European Heart Journal. Cardiovascular Imaging|September 5, 2020
Sex differences in the association between myocardial function and prognosis in type 1 diabetes without known heart disease: the Thousand & 1 StudyMats Christian Højbjerg Lassen, Tor Biering-Sørensen, Peter Godsk Jørgensen, et al.
Respiratory Medicine|July 10, 2026
Beta-blockers and mortality after myocardial infarction in patients with and without chronic obstructive pulmonary disease - A Danish nationwide cohort study of 96,567 patientsDaniel B Rasmussen, Howraman Meteran, Morten Lamberts, et al.
JACC. Cardiovascular Imaging|February 17, 2020
Post-Systolic Shortening by Speckle Tracking Echocardiography Predicts Cardiac Events in Type 2 DiabetesPhilip Brainin, Magnus T Jensen, Tor Biering-Sørensen, et al.
European Heart Journal. Cardiovascular Imaging|August 28, 2023
Prognostic value of myocardial performance index in individuals with type 1 and type 2 diabetes: Thousand&1 and Thousand&2 studiesHashmat Sayed Zohori Bahrami, Peter Godsk Jørgensen, Jens Dahlgaard Hove, et al.
Cardiovascular Diabetology|September 1, 2019
Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetesRegitse H Christensen, Bernt Johan von Scholten, Christian S Hansen, et al.
International Journal of Cardiology|May 13, 2019
An echocardiographic substrate for dyspnea identifies high risk patients with type 2 diabetesPeter G Jørgensen, Morten Schou, Tor Biering-Sørensen, et al.
Diabetes, Obesity & Metabolism|February 12, 2017
Effect of exercise combined with glucagon-like peptide-1 receptor agonist treatment on cardiac function: A randomized double-blind placebo-controlled clinical trialPeter G Jørgensen, Magnus T Jensen, Pernille Mensberg, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|November 2, 2020
Prognostic Value of Early Systolic Lengthening by Strain Imaging in Type 2 DiabetesPhilip Brainin, Tor Biering-Sørensen, Magnus T Jensen, et al.
Journal of Diabetes and Its Complications|April 29, 2020
Effect of dapagliflozin on cardiac function in people with type 2 diabetes and albuminuria - A double blind randomized placebo-controlled crossover trialMie K Eickhoff, Flemming J Olsen, Marie Frimodt-Møller, et al.
Pageof 8